Close Menu

NEW YORK (GenomeWeb) – LifeCodexx announced today that it has signed an agreement to sell its PrenaTest noninvasive prenatal screening test in India through preventative healthcare provider LifeCell.

According to LifeCodexx, LifeCell will offer the test under its BabyShield brand. Additional terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.